HopeStage
Back to all studies
CompletedEUCTR 2014-000354-11

The Efficacy of Ibogaine in the Treatment of Addiction; an open label, single fixed dose pilot-study of the efficacy of ibogaine in opioid-dependent subjects

This historical record does not confirm current site availability.

Historical research recordNetherlands
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Netherlands
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
Radboud UMC
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Netherlands
Age range
Not clearly listed
Official registry ID
EUCTR 2014-000354-11
Official title
Show the full official title

The Efficacy of Ibogaine in the Treatment of Addiction; an open label, single fixed dose pilot-study of the efficacy of ibogaine in opioid-dependent subjects

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Netherlands

Registry details
Historical country statuses
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Radboud UMC.

Want to explore more studies?

Explore studies